Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
25 avr. 2024 09h00 HE
|
Medigene AG
Planegg/Martinsried, April 25, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Medigene to Present at Upcoming Scientific Conferences
17 avr. 2024 06h00 HE
|
Medigene AG
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, has been...
Baby Independent Innovation Announces Winners of 2023 Awards Program
18 juil. 2023 08h00 HE
|
Baby Innovation Awards
LOS ANGELES, July 18, 2023 (GLOBE NEWSWIRE) -- The 2023 Baby Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
Medigene Presents Enhanced Tumor Cell Killing Effects upon Addition of PD1-41BB Switch Receptor to TCR-T Therapies
22 juin 2023 12h10 HE
|
Medigene AG
Planegg/Martinsried, 22 June 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...
PSYC Offers Fresh Look at Emerging Psilocybin Community with July Newsletter
15 juil. 2020 08h30 HE
|
Global Trac Solutions, Inc.
LAS VEGAS, July 15, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce the 2nd monthly release and distribution of the...
Rezolute Initiates Phase 2b Clinical Trial of Lead Candidate RZ358 in Congenital Hyperinsulinism
10 févr. 2020 08h30 HE
|
Rezolute, Inc.
REDWOOD CITY, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (OTCQB:RZLT), today announced the initiation of the RIZE study (RZ358-606), a Phase 2b clinical...
Rezolute to Present at BIO CEO & Investor Conference 2020
27 janv. 2020 08h30 HE
|
Rezolute, Inc.
REDWOOD CITY, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (OTCQB:RZLT), today announced an upcoming presentation regarding the company’s clinical...
DiGennaro Communications Names Maxine Winer President & Chief Operating Officer
10 janv. 2020 09h23 HE
|
DiGennaro Communications
NEW YORK, Jan. 10, 2020 (GLOBE NEWSWIRE) -- DiGennaro Communications (DGC), the leading independent B2B public relations agency serving the media, marketing and entertainment sectors, has named...
PARC Scientists Honored, PARC Innovation Business Strategy Recognized
05 févr. 2013 07h18 HE
|
PARC Inc.
Palo Alto, Feb. 5, 2013 (GLOBE NEWSWIRE) -- PARC, a Xerox company,
today announced that Victoria Bellotti, Scott Elrod, Jose Joaquin
(J.J.) Garcia-Luna-Aceves and Lawrence Lee were honored...
PGS Signs Amendment to Agreement with Sinochem for the Sale of the Atlantis Subsidiary
24 janv. 2003 12h38 HE
|
Petroleum Geo-Services ASA
OLSO, Norway, Jan. 24, 2003 (PRIMEZONE) -- Petroleum Geo-Services ASA ('PGS') (NYSE:PGO) (Oslo:PGS) announced today that it has agreed to terms and signed an amendment to the agreement with China...